Trial Profile
An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2012
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Moxifloxacin (Primary) ; Moxifloxacin/dexamethasone (Primary)
- Indications Bacterial infections; Blepharitis; Conjunctivitis; Keratitis; Ophthalmic infections
- Focus Registrational; Therapeutic Use
- 21 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2008 New trial record.